Bunkerhill AVC vs prolaio eVO2peak Module

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Bunkerhill AVC

by Bunkerhill Health

prolaio eVO2peak Module

by Prolaio

AI Verdict

Tool A specializes in the automated detection and quantification of calcifications and bone density from CT scans, offering insights into structural cardiac and bone health. In contrast, Tool B estimates peak oxygen consumption using wearable sensor data, focusing on cardiovascular fitness and functional capacity. While both are FDA-cleared AI solutions for cardiology, they address different clinical problems with distinct data inputs and outputs.

Choose Bunkerhill AVC if…

Choose Bunkerhill AVC if your health system aims to leverage generative AI for automated, opportunistic screening of cardiovascular and bone health indicators directly from existing CT imaging. This tool is ideal for integrating seamlessly with EHRs to enhance early detection and quantification of conditions like aortic valve calcification, coronary artery calcification, and bone density, thereby improving diagnostic workflows and patient outcomes.

View Bunkerhill AVC →

Choose prolaio eVO2peak Module if…

Choose prolaio eVO2peak Module if you require an FDA-cleared, cloud-based solution to estimate peak oxygen consumption (VO2peak) using real-world data from wearable sensors. This module is best suited for cardiovascular research and clinical care settings where longitudinal, high-density monitoring of cardiorespiratory fitness is crucial, especially when traditional exercise testing is impractical or for remote patient assessment.

View prolaio eVO2peak Module →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Bunkerhill AVC	prolaio eVO2peak Module
Deployment	Unknown	Cloud
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Bunkerhill AVC

Tool A, Bunkerhill AVC, integrates directly with full Electronic Health Records (EHRs) and clinical archives, and features natural language processing for patient record interaction (Carebricks Chat). This deep integration and conversational AI suggest a more seamless and intuitive user experience within existing clinical workflows compared to Tool B's reliance on external wearable sensor data.

Clinical Value

Bunkerhill AVC

Both tools offer significant, FDA-cleared clinical value. However, Tool A (Bunkerhill AVC) provides opportunistic detection and quantification of multiple critical cardiovascular calcifications and bone density from widely available CT scans, impacting a broad patient population. Its generative AI for clinical reasoning further enhances its utility for comprehensive decision support.

Pricing & Value

Tie

Both Bunkerhill AVC and prolaio eVO2peak Module state 'contact for pricing,' and no public pricing information is available for either product. Without transparent pricing details, it is impossible to conduct a head-to-head comparison of their cost or assess which offers superior value.

Enterprise Readiness

Bunkerhill AVC

Both tools are FDA-cleared, HIPAA compliant, and offer Business Associate Agreements (BAAs), indicating enterprise readiness. However, Tool A (Bunkerhill AVC) explicitly states integration with 'full Electronic Health Records (EHRs) and clinical archives within health systems,' suggesting a more deeply embedded and potentially less disruptive deployment model for large healthcare organizations.

Innovation

Bunkerhill AVC

While Tool B's non-invasive estimation of eVO2peak from wearable data using a deep-learning model is innovative, Tool A (Bunkerhill AVC) pushes the boundaries further with its 'Generative AI for clinical reasoning and action' and 'Natural language processing for patient record interaction (Carebricks Chat).' This suggests a broader application of advanced AI beyond specific detection or prediction, moving towards more dynamic clinical intelligence.

Support & Docs

Tie

Neither the provided structured facts nor general web searches offer specific details regarding the customer support structures, training programs, or public documentation available for either Bunkerhill Health or Prolaio. Therefore, it is not possible to distinguish between the two products on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Bunkerhill AVC	prolaio eVO2peak Module
Name	Bunkerhill AVC	prolaio eVO2peak Module
Company	BunkerHill Health	Prolaio
Tagline	Generative AI for clinical reasoning and action.	Heart care, connected.
Description	Bunkerhill Health provides a generative AI platform, Carebricks, for clinical reasoning and action, integrating with EHRs to automate workflows and improve patient outcomes. Its FDA-cleared algorithm, Bunkerhill AVC, specifically aids in the early detection and quantification of aortic valve calcification from chest CTs.	Prolaio is a clinical intelligence company that develops FDA-cleared software, such as the eVO2peak Module, to estimate peak oxygen consumption using real-world patient data for cardiovascular research and care.
Primary Function	Automated detection and quantification of aortic valve calcification (Bunkerhill AVC); Generative AI for clinical reasoning and action	Estimates peak oxygen consumption (eVO2peak)
Key Features	Generative AI for clinical reasoning and action, Automated detection and quantification of aortic valve calcification (Bunkerhill AVC), Automated detection and quantification of coronary artery calcification (iCAC, Contrast CAC), Automated detection and quantification of mitral annular calcification (Bunkerhill MAC), Opportunistic bone density assessment (Bunkerhill BMD), Integration with Electronic Health Records (EHRs) and clinical archives, Customizable AI agents for diverse workflows, Natural language processing for patient record interaction (Carebricks Chat)	Estimates peak oxygen consumption (eVO2peak), Utilizes demographic data, single-lead ECG, and triaxial accelerometry inputs, Processes data from qualified third-party FDA-cleared wearable medical sensors, Applies a locked deep-learning model for eVO2peak estimation, Provides information as an adjunctive aid in clinical evaluation, Enables high-density, longitudinal data collection, Leverages real-world patient data and insights, Features FDA-cleared software and proprietary algorithms
Specialties	Cardiology, Radiology	Cardiology, Physical Medicine & Rehab, Sports Medicine

Videos

Demos, reviews, and walkthroughs featuring Bunkerhill AVC and prolaio eVO2peak Module.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications of each tool?

Bunkerhill AVC focuses on the automated detection and quantification of various calcifications (aortic valve, coronary artery, mitral annular) and opportunistic bone density assessment from chest CTs, aiding in early disease detection and clinical reasoning. Prolaio eVO2peak Module estimates peak oxygen consumption (eVO2peak) using real-world patient data from wearable sensors, providing an adjunctive aid in clinical evaluation for cardiovascular research and care.

What type of patient data do these tools utilize?

Bunkerhill AVC primarily analyzes chest CT scans to identify and quantify calcifications and assess bone density. Prolaio eVO2peak Module processes demographic data, single-lead ECG, and triaxial accelerometry inputs obtained from qualified third-party FDA-cleared wearable medical sensors.

How do these tools integrate into existing clinical IT infrastructure?

Bunkerhill AVC integrates with full Electronic Health Records (EHRs) and clinical archives within health systems. Prolaio eVO2peak Module is a cloud-based, software-only solution that processes remote sensor data.

Which medical specialties are these tools designed to support?

Bunkerhill AVC is designed to support Cardiology and Radiology. Prolaio eVO2peak Module supports Cardiology, Physical Medicine & Rehab, and Sports Medicine.

What specific metrics or insights do these tools provide?

Bunkerhill AVC provides automated detection and quantification of aortic valve calcification (AVC), coronary artery calcification (iCAC, Contrast CAC), mitral annular calcification (MAC), and opportunistic bone density assessment (BMD). Prolaio eVO2peak Module estimates peak oxygen consumption (eVO2peak) and offers this information as an adjunctive aid in clinical evaluation.

What is the underlying AI methodology used by each tool?

Bunkerhill AVC is part of a generative AI platform, Carebricks, for clinical reasoning and action, utilizing FDA-cleared algorithms for specific detections and a deep-learning model for detecting aortic valve calcification. Prolaio eVO2peak Module applies a locked deep-learning model for eVO2peak estimation.